These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 274123)

  • 21. [4.5 percent human albumin and polyvalent resuscitation. Initial evaluation after perfusion of 250 flasks].
    Bourdais A; Lebris H; Mayère JP
    Dakar Med; 1982; 27(4):527-35. PubMed ID: 7184738
    [No Abstract]   [Full Text] [Related]  

  • 22. Colloid or crystalloid for resuscitation of major burns.
    Hemington-Gorse SJ
    J Wound Care; 2005 Jun; 14(6):256-8. PubMed ID: 15974411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploding the albumin myth.
    Tjoeng MM; Bartelink AK; Thijs LG
    Pharm World Sci; 1999 Feb; 21(1):17-20. PubMed ID: 10214663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dud cigar?--Cochrane collaboration and the saga of human albumin.
    Bell E
    Adverse Drug React Toxicol Rev; 1999 Aug; 18(3):149-63. PubMed ID: 10592836
    [No Abstract]   [Full Text] [Related]  

  • 25. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
    London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
    J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight dextran infusion is more effective for the treatment of hemoconcentration due to severe ovarian hyperstimulation syndrome than human albumin infusion.
    Endo T; Kitajima Y; Hayashi T; Fujii M; Hata H; Azumaguchi A
    Fertil Steril; 2004 Nov; 82(5):1449-51. PubMed ID: 15533378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry.
    Brinkman AC; Romijn JW; van Barneveld LJ; Greuters S; Veerhoek D; Vonk AB; Boer C
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):422-6. PubMed ID: 20056447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical use of a human albuminoid preparation (SPPS) produced by the continuous small volume mixing (CSVM) fractionation technique.
    Cash JD
    Dev Biol Stand; 1980; 48():43-8. PubMed ID: 7274563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of plasma expanders in toxemia of pregnancy.
    Cloeren SE; Lippert TH
    N Engl J Med; 1972 Dec; 287(26):1356-7. PubMed ID: 4635026
    [No Abstract]   [Full Text] [Related]  

  • 30. Ventilation, cardiopulmonary bypass, and acute respiratory distress syndrome: Are the lungs the problem?
    Lyons WS
    Crit Care Med; 2001 Feb; 29(2):463-5. PubMed ID: 11246337
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rational use of albumin].
    Sikuler E; Shapira A; Mor-Yosef S; Shlaeffer P; Slovik D; Brutin M; Gurman G
    Harefuah; 2000 Sep; 139(5-6):190-3, 246. PubMed ID: 11062949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human albumin solutions: consensus statements for use in selected clinical situations. Subcommittee of the Victorian Drug Usage Advisory Committee.
    Med J Aust; 1992 Sep; 157(5):340-3. PubMed ID: 1435481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of autologous blood as part of the perfusate for cardiopulmonary bypass: a priming technique.
    Myers GJ; Legare JF; Sullivan JA; Leadon RB; Johnstone R; Swyer W; Squires C; Power C; Hirsch GM
    Perfusion; 2002 May; 17(3):211-6. PubMed ID: 12017390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications for the use of human albumin solutions: an expert report. Human albumin expert group].
    Schweiz Med Wochenschr; 2000 Apr; 130(14):516-22. PubMed ID: 10804604
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients.
    Tigchelaar I; Gallandat Huet RC; Boonstra PW; van Oeveren W
    Perfusion; 1998 Sep; 13(5):297-303. PubMed ID: 9778712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass.
    Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W
    Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human albumin and colloid fluid replacement: their use in general surgery.
    Camu F; Ivens D; Christiaens F
    Acta Anaesthesiol Belg; 1995; 46(1):3-18. PubMed ID: 7618426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of albumin on serum protein homeostasis after hypovolemic shock.
    Bouwman DL; Weaver DW; Vega J; Ledgerwood AM; Higgins R; Lucas CE
    J Surg Res; 1978 Apr; 24(4):229-34. PubMed ID: 642493
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of plasma volume expanders in myocardial revascularisation.
    Lacy JH; Wright CB
    Drugs; 1992 Nov; 44(5):720-7. PubMed ID: 1280564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Are there still indications for albumin?].
    Simpson K
    Wien Klin Wochenschr; 1999 Jun; 111(11):448-9; author reply 451-3. PubMed ID: 10420498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.